1.
Shalini K, F M, M J, et al. To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus. IJRPLS. 2024;12(02):31-37. doi:10.30904/j.ijrpls.2024.4722